MedTrace Logo

Lidocaine as an Adjuvant for Ketamine in Induction of Anesthesia in Septic Shock Patients

NCT03640468 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2018-11-21

No results posted yet for this study

Summary

The aim of the work is to investigate the effect of using lidocaine in combination with low dose ketamine in induction of anesthesia for septic shock patients compared to normal dose of ketamine.

Conditions

  • Septic Shock
  • Anesthesia

Interventions

DRUG

Ketamine full dose

This group will receive induction of anesthesia using Ketamine 1 mg/Kg

DRUG

Ketamine half dose

This group will receive induction of anesthesia using Ketamine 0.5 mg/Kg

DRUG

Lidocaine

This group will receive lidocaince 1 mg/Kg

DRUG

Midazolam

This group will receive midazolam 0.05 mg/Kg

DRUG

Normal saline

This group will receive normal saline 10 mL

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Ahmed Hasanin, Professor · Assistant professor of anesthesia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-20
Primary Completion
2019-06-15
Completion
2019-07-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03640468 on ClinicalTrials.gov